Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 4, 2019 Off

Innovation and Unmet Need Drive Prescription Drug Sales to $1.18tr by 2024: New Report from Evaluate Ltd

By BusinessWire

“EvaluatePharma® World Preview 2019, Outlook to 2024” explores growth drivers, growth brakes and top industry performers. LONDON & BOSTON &…

June 4, 2019 Off

Re-Vana Therapeutics Names Renowned International Experts to Inaugural Scientific Advisory Board

By BusinessWire

New International Team Brings Extensive Ocular Drug Delivery and Scientific Expertise to Advance the Sustained Release of Biologics and Small…

June 4, 2019 Off

Glytec Developing Novel Solution for Selection and Dosing of All Diabetes Medications

By BusinessWire

New product will be the market’s first and only to enable optimization of ALL diabetes medications, insulin and non-insulin alike.…

June 4, 2019 Off

Strand Therapeutics Announces $6 Million Seed Financing to Advance its Programmable mRNA Therapeutics Platform

By BusinessWire

Seed round led by Playground Global to focus on the advancement of next-generation mRNA-based cancer immunotherapies and development of its…

June 4, 2019 Off

NantKwest Announces Updated Clinical Results for Nanatinostat (VRx-3996), a Novel HDAC Inhibitor Being Developed in Partnership with Viracta Therapeutics

By BusinessWire

Phase Ib/II Clinical Trial Data Reported at 2019 Annual Meeting of the American Society of Clinical Oncology Shows High Overall…

June 4, 2019 Off

Celgene Corporation and Acceleron Pharma Announce U.S. FDA Accepts Luspatercept Biologics License Application in Myelodysplastic Syndromes and Beta-Thalassemia

By BusinessWire

U.S. Food and Drug Administration grants priority review for beta-thalassemia indication and sets target action date of December 4, 2019…

June 4, 2019 Off

Incyte Announces First Patient Treated in Phase 3 Clinical Trial of Pemigatinib as a First-Line Therapy for Cholangiocarcinoma

By BusinessWire

WILMINGTON, Del.–(BUSINESS WIRE)–$INCY–Incyte (Nasdaq:INCY) today announced that the first patient has been treated in FIGHT-302, an open-label Phase 3 study…

June 4, 2019 Off

Kraig Biocraft Laboratories Promotes Dr. Trevor Kane to Chief Scientist

By BusinessWire

Kraig Labs R&D Team continues to deliver outstanding breakthroughs ANN ARBOR, Mich.–(BUSINESS WIRE)–$KBLB #KBLB–Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”),…

June 4, 2019 Off

Dicerna™ Appoints Rob Ciappenelli Chief Commercial Officer

By BusinessWire

— Company Expands Management Team and Bolsters Commercial Capabilities to Support Continued Growth — CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dicerna™ Pharmaceuticals, Inc. (Nasdaq:DRNA)…

June 4, 2019 Off

KalVista Pharmaceuticals Presents KVD900 Data at European Academy of Allergy and Clinical Immunology

By BusinessWire

– KVD900 Demonstrates Rapid and Nearly Complete Suppression of Plasma Kallikrein Activity in a Phase 1 Study – CAMBRIDGE, Mass.…

Posts pagination

Previous 1 … 3,133 3,134 3,135 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine